FDA panel finds new Alzheimer's drug slowed cognitive decline

FDA panel finds new Alzheimer's drug slowed cognitive declineПодробнее

FDA greenlights new Alzheimer's drug amid safety concernsПодробнее

FDA Approves First Drug That Slows Cognitive Decline In Alzheimer's PatientsПодробнее

Alzheimer's drug lecanemab can slow cognitive decline, study showsПодробнее

FDA panel approves Alzheimer's drug that can slow diseaseПодробнее

Experimental Alzheimer's drug slowed cognitive decline in clinical trialПодробнее

FDA approves new drug to slow progression of Alzheimer'sПодробнее

FDA approves first drug to slow Alzheimer's: What to knowПодробнее

Experimental Alzheimer’s Drug Appears To Slow Cognitive DeclineПодробнее

FDA panel approves Alzheimer's drug that can slow diseaseПодробнее

New Alzheimer's drug approved by FDA to slow cognitive declineПодробнее

FDA approves breakthrough Alzheimer's drugПодробнее

US government approves Alzheimer’s drug to slow cognitive declineПодробнее

Eli Lilly Alzheimers drug slows cognitive declineПодробнее

FDA approves drug shown to slow cognitive decline in early-stage Alzheimer's patientsПодробнее

FDA grants full approval for Alzheimer's drug shown to modestly slow cognitive declineПодробнее

Experimental Alzheimer's drug may slow progression, but with significant side effects, study showsПодробнее

FDA panel approves Alzheimer's drug that can slow diseaseПодробнее

Alzheimer's treatment: New drug slows cognitive decline by 35%, studies show • FRANCE 24 EnglishПодробнее

Alzheimer's drug, which slows the cognitive decline, gets FDA approvalПодробнее